Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at http://www.ucl.ac.uk/finance/research/post_award/post_award_contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Prof Kerry Chester
UCL Cancer Institute, Paul O'Gorman Building
72 Huntley Street
  • Professor of Molecular Medicine
  • Research Department of Oncology
  • Cancer Institute
  • Faculty of Medical Sciences
UCL Principal Supervisor,UCL Subsidiary Supervisor
Research Summary
Kerry leads the Recombinant Antibody Therapeutics Group at the UCL Cancer Institute. Her main research interests are design and construction of antibody-based therapeutics and the interaction of these molecules with cancer targets. The basic antibody fragment used is the single chain Fv (scFv) and constructs such as scFv fusion proteins with enzymes or albumin are explored. There is a focus on Bench-to-Bedside and the Group has a licensed Production Facility to make antibody-based therapeutics in compliance with Good Manufacturing Practice (GMP). The Cancer Institute offers a unique opportunity for translational work as facilities are available for basic research, pre-clinical testing and Phase I clinical trials.
Academic Background
1984   Doctor of Philosophy University of London
1974   Bachelor of Science (Honours) University of Salford
Please report any queries concerning the data shown on this page to https://www.ucl.ac.uk/hr/helpdesk/helpdesk_web_form.php
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by